Thomas Jefferson University

Ronald Myers

TitleProfessor
InstitutionThomas Jefferson University
DepartmentMedical Oncology
Address834 Chestnut Street
Philadelphia PA 19107
Phone215-503-4085
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R03CA046501     (MYERS, RONALD E)Sep 25, 1987 - Sep 24, 1988
    NIH
    INCREASING PARTICIPATION IN A COLO-RECTAL SCREENING
    Role: Principal Investigator
    R01CA067464     (MYERS, RONALD E)Sep 30, 1994 - Sep 29, 1998
    NIH
    PROSTATE SCREENING ADHERENCE IN AFRICAN AMERICAN MEN
    Role: Principal Investigator
    R01CA068683     (MYERS, RONALD E)Jul 20, 1997 - Apr 30, 2002
    NIH
    ENHANCING DIAGNOSTIC EVALUATION IN COLORECTAL CANCER
    Role: Principal Investigator
    U01CA086084     (MYERS, RONALD E)Apr 4, 2000 - Sep 30, 2006
    NIH
    INCREASING ACCESS TO CLINICAL AND EDUCATIONAL STUDIES
    Role: Principal Investigator
    R01CA084140     (MYERS, RONALD E)Jun 1, 2001 - Nov 30, 2006
    NIH
    Increasing Colon Cancer Screening in Primary Care
    Role: Principal Investigator
    R21CA102418     (MYERS, RONALD E)Jul 21, 2004 - Dec 31, 2006
    NIH
    Tailored Messaging in Colorectal Cancer Screening
    Role: Principal Investigator
    R01CA116576     (MYERS, RONALD E)Jan 1, 2007 - Dec 31, 2011
    NIH
    Tailored Navigation in CRC Screening
    Role: Principal Investigator
    R01CA258849     (MYERS, RONALD E.)Jul 1, 2022 - Jun 30, 2027
    NIH
    Provider Support and Patient Outreach in Lung Cancer Screening
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Jeminiwa R, Park S, Popielaski C, Gannon M, Myers R, Abatemarco DJ. Development of an Educational Brochure about Treatment Options for Pregnant Women with Opioid Use Disorders. Pharmacy (Basel). 2024 Jun 22; 12(4). PMID: 39051381.
      Citations:    
    2. Myers RE, Hallman MH, Shimada A, DiCarlo MA, Davis KV, Leach WT, Chambers CV. Primary care patient interests in joining a planned multi-cancer early detection clinical trial. Cancer Med. 2024 May; 13(10):e7312. PMID: 38785202.
      Citations:    
    3. Zhang Z, Luo R, Kelly WK, Chen J, Donahue S, Ip K, Handley NR, Tester WJ, Tsang ML, Kim FJ, Myers R, Lu-Yao G, Gu J, Lin J, Li B, Wang C, Yang H. Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2023 Dec 06. PMID: 38057610.
      Citations:    
    4. Chambers CV, Leach WT, Davis K, Myers RE. Primary Care Provider Receptivity to Multi-Cancer Early Detection Test Use in Cancer Screening. J Pers Med. 2023 Nov 29; 13(12). PMID: 38138900.
      Citations:    
    5. Bittner Fagan H, Jurkovitz C, Zhang Z, Thompson LA, Patterson F, Zazzarino MA, Myers RE. Primary care outreach and decision counseling for lung cancer screening. J Med Screen. 2023 Nov 21; 9691413231213495. PMID: 37990545.
      Citations:    
    6. Myers RE, Hallman MH, Shimada A, DiCarlo M, Davis K, Leach WT, Jackson H, Indictor A, Chambers CV. Primary Care Patient Interest in Multi-Cancer Early Detection for Cancer Screening. J Pers Med. 2023 Nov 16; 13(11). PMID: 38003928.
      Citations:    
    7. Barta JA, Erkmen CP, Shusted CS, Myers RE, Saia C, Cohen S, Wainwright J, Zeigler-Johnson C, Dako F, Wender R, Kane GC, Vachani A, Rendle KA. The Philadelphia Lung Cancer Learning Community: A Multi-Health-System, Citywide Approach to Lung Cancer Screening. JNCI Cancer Spectr. 2023 Sep 15. PMID: 37713466.
      Citations:    
    8. Myers R, Hallman MH, Davis K, DiCarlo M, Daskalakis C, Shimada A, Chambers C. Primary care provider perspectives on a planned multi-cancer early detection test clinical trial. Contemp Clin Trials Commun. 2023 Aug; 34:101183. PMID: 37456505.
      Citations:    
    9. Daskalakis C, Shimada A, Myers RE, Eastburn K, DiCarlo MA, Shusted CS, Barta JA. Decision Preferences in Shared Decision-Making for Lung Cancer Screening Among White and African American Individuals. Ann Am Thorac Soc. 2023 Feb 24. PMID: 36827233.
      Citations:    
    10. Davis KV, Hallman MH, DiCarlo M, Wambua SM, Jaffe RL, Welsh AW, Kerber C, Yang H, Chambers CV, Myers RE. Factors Likely to Affect the Uptake of Genomic Approaches to Cancer Screening in Primary Care: A Scoping Review. J Pers Med. 2022 Dec 10; 12(12). PMID: 36556264.
      Citations:    
    11. Abu-Khalaf M, Wang C, Zhang Z, Luo R, Chong W, Silver DP, Fellin F, Jaslow R, Lopez A, Cescon T, Jiang W, Myers R, Wei Q, Li B, Cristofanilli M, Yang H. Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism. Cancers (Basel). 2022 Jun 10; 14(12). PMID: 35740538.
      Citations:    
    12. DiCarlo M, Myers P, Daskalakis C, Shimada A, Hegarty S, Zeigler-Johnson C, Juon HS, Barta J, Myers RE. Outreach to primary care patients in lung cancer screening: A randomized controlled trial. Prev Med. 2022 Jun; 159:107069. PMID: 35469777.
      Citations:    
    13. Myers RE, Advani SM, Myers P, Selvan P, Garber G, Worster B, Flomenberg N, Chapman A, Zinner R. Engaging Patients with Late-Stage Non-Small Cell Lung Cancer in Shared Decision Making about Treatment. J Pers Med. 2021 Oct 01; 11(10). PMID: 34683140.
      Citations:    
    14. Dayaratna S, Sifri R, Jackson R, Powell R, Sherif K, DiCarlo M, Hegarty SE, Petrich A, Lambert E, Quinn A, Myers R. Preparing women experiencing symptoms of menopause for shared decision making about treatment. Menopause. 2021 07 12; 28(9):1060-1066. PMID: 34260477.
      Citations:    
    15. Barta JA, Shusted CS, Ruane B, Pimpinelli M, McIntire RK, Zeigler-Johnson C, Myers RE, Evans NR, Kane GC, Juon HS. Racial Differences in Lung Cancer Screening Beliefs and Screening Adherence. Clin Lung Cancer. 2021 Jun 13. PMID: 34257020.
      Citations:    
    16. Chong W, Zhang Z, Luo R, Gu J, Lin J, Wei Q, Li B, Myers R, Lu-Yao G, Kelly WK, Wang C, Yang H. Integration of circulating tumor cell and neutrophil-lymphocyte ratio to identify high-risk metastatic castration-resistant prostate cancer patients. BMC Cancer. 2021 Jun 02; 21(1):655. PMID: 34078304.
      Citations:    
    17. Luo R, Chong W, Wei Q, Zhang Z, Wang C, Ye Z, Abu-Khalaf MM, Silver DP, Stapp RT, Jiang W, Myers RE, Li B, Cristofanilli M, Yang H. Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer. NPJ Breast Cancer. 2021 Jun 01; 7(1):72. PMID: 34075047.
      Citations:    
    18. Vernon SW, Del Junco DJ, Coan SP, Murphy CC, Walters ST, Friedman RH, Bastian LA, Fisher DA, Lairson DR, Myers RE. A stepped randomized trial to promote colorectal cancer screening in a nationwide sample of U.S. Veterans. Contemp Clin Trials. 2021 Apr 03; 105:106392. PMID: 33823295.
      Citations:    
    19. Wang C, Zhang Z, Chong W, Luo R, Myers RE, Gu J, Lin J, Wei Q, Li B, Rebbeck TR, Lu-Yao G, Kelly WK, Yang H. Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate Cancer. Cancers (Basel). 2021 Jan 13; 13(2). PMID: 33450815.
      Citations:    
    20. Myers RE. Health Organizations Have an Opportunity to Improve Shared Decision-Making and Raise Lung Cancer Screening Rates. Chest. 2021 Jan; 159(1):23-24. PMID: 33422199.
      Citations:    
    21. Abubaker-Sharif M, Shusted C, Myers P, Myers R. Primary Care Physician Perceptions of Shared Decision Making in Lung Cancer Screening. J Cancer Educ. 2020 Nov 23. PMID: 33230673.
      Citations:    
    22. Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons JK, Carroll PR, Pilarski R, Blanco A, Woodson A, Rahm A, Taplin ME, Polascik TJ, Helfand BT, Hyatt C, Morgans AK, Feng F, Mullane M, Powers J, Concepcion R, Lin DW, Wender R, Mark JR, Costello A, Burnett AL, Sartor O, Isaacs WB, Xu J, Weitzel J, Andriole GL, Beltran H, Briganti A, Byrne L, Calvaresi A, Chandrasekar T, Chen DYT, Den RB, Dobi A, Crawford ED, Eastham J, Eggener S, Freedman ML, Garnick M, Gomella PT, Handley N, Hurwitz MD, Izes J, Karnes RJ, Lallas C, Languino L, Loeb S, Lopez AM, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann M, Mille P, Miner MM, Morgan T, Moreno J, Mucci L, Myers RE, Nielsen SM, O'Neil B, Pinover W, Pinto P, Poage W, Raj GV, Rebbeck TR, Ryan C, Sandler H, Schiewer M, Scott EMD, Szymaniak B, Tester W, Trabulsi EJ, Vapiwala N, Yu EY, Zeigler-Johnson C, Gomella LG. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. J Clin Oncol. 2020 Jun 09; JCO2000046. PMID: 32516092.
      Citations:    
    23. Wang C, Mu Z, Ye Z, Zhang Z, Abu-Khalaf MM, Silver DP, Palazzo JP, Jagannathan G, Fellin FM, Bhattacharya S, Jaslow RJ, Tsangaris TN, Berger A, Neupane M, Cescon TP, Lopez A, Yao K, Chong W, Lu B, Myers RE, Hou L, Wei Q, Li B, Cristofanilli M, Yang H. Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors. Breast Cancer Res Treat. 2020 May 04. PMID: 32367460.
      Citations:    
    24. Daskalakis C, DiCarlo M, Hegarty S, Gudur A, Vernon SW, Myers RE. Predictors of overall and test-specific colorectal Cancer screening adherence. Prev Med. 2020 Feb 08; 133:106022. PMID: 32045616.
      Citations:    
    25. Myers RE. Low rates of diagnostic colonoscopy in Federally Qualified Health Centers: A persistent problem that must be addressed to achieve the promise of colorectal cancer screening. Cancer. 2019 Sep 03. PMID: 31479509.
      Citations:    
    26. Fagan HB, Fournakis NA, Jurkovitz C, Petrich AM, Zhang Z, Katurakes N, Myers RE. Telephone-Based Shared Decision-making for Lung Cancer Screening in Primary Care. J Cancer Educ. 2019 May 09. PMID: 31069714.
      Citations:    
    27. MacKenzie AR, Barsevick AM, Myers R, Hegarty SE, Keith SW, Patel S, Lapinsky E, Schoppe J, Williams U, Chapman AE. Treatment plan consistency with guidelines for older adults with cancer. J Geriatr Oncol. 2019 Mar 06. PMID: 30852179.
      Citations:    
    28. Weinstein L, LaNoue M, Hurley K, Payton C, Sifri R, Myers R. Feasibility Pilot Outcomes of a Mammography Decision Support and Navigation Intervention for Women With Serious Mental Illness Living in Supportive Housing Settings. J Prim Care Community Health. 2019 Jan-Dec; 10:2150132719867587. PMID: 31416398.
      Citations:    
    29. Ye Z, Wang C, Wan S, Mu Z, Zhang Z, Abu-Khalaf MM, Fellin FM, Silver DP, Neupane M, Jaslow RJ, Bhattacharya S, Tsangaris TN, Chervoneva I, Berger A, Austin L, Palazzo JP, Myers RE, Pancholy N, Toorkey D, Yao K, Krall M, Li X, Chen X, Fu X, Xing J, Hou L, Wei Q, Li B, Cristofanilli M, Yang H. Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA. Eur J Cancer. 2019 Jan; 106:133-143. PMID: 30528798.
      Citations:    
    30. Shusted CS, Barta JA, Lake M, Brawer R, Ruane B, Giamboy TE, Sundaram B, Evans NR, Myers RE, Kane GC. The Case for Patient Navigation in Lung Cancer Screening in Vulnerable Populations: A Systematic Review. Popul Health Manag. 2018 Nov 08. PMID: 30407102.
      Citations:    
    31. Man LC, DiCarlo M, Lambert E, Sifri R, Romney M, Fleisher L, Myers R. A learning community approach to identifying interventions in health systems to reduce colorectal cancer screening disparities. Prev Med Rep. 2018 Dec; 12:227-232. PMID: 30370210.
      Citations:    
    32. Myers RE, Stello B, Daskalakis C, Sifri R, Gonzalez ET, DiCarlo M, Johnson MB, Hegarty SE, Shaak K, Rivera A, Gordils-Molina L, Petrich A, Careyva B, de-Ortiz R, Diaz L. Decision Support and Navigation to Increase Colorectal Cancer Screening among Hispanic Patients. Cancer Epidemiol Biomarkers Prev. 2018 Oct 17. PMID: 30333221.
      Citations:    
    33. Myers RE, DiCarlo M, Romney M, Fleisher L, Sifri R, Soleiman J, Lambert E, Rosenthal M. Using a health system learning community strategy to address cancer disparities. Learn Health Syst. 2018 Oct; 2(4):e10067. PMID: 31245591.
      Citations:    
    34. Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. J Clin Oncol. 2018 Feb 01; 36(4):414-424. PMID: 29236593.
      Citations:    
    35. Wan S, Hann HW, Ye Z, Hann RS, Lai Y, Wang C, Li L, Myers RE, Li B, Xing J, Yang H. Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients. Carcinogenesis. 2017 Apr 01; 38(4):439-446. PMID: 28334112.
      Citations:    
    36. Ritvo P, Myers RE, Serenity M, Gupta S, Inadomi JM, Green BB, Jerant A, Tinmouth J, Paszat L, Pirbaglou M, Rabeneck L. Taxonomy for colorectal cancer screening promotion: Lessons from recent randomized controlled trials. Prev Med. 2017 Aug; 101:229-234. PMID: 28024865.
      Citations:    
    37. Wang C, Mu Z, Chervoneva I, Austin L, Ye Z, Rossi G, Palazzo JP, Sun C, Abu-Khalaf M, Myers RE, Zhu Z, Ba Y, Li B, Hou L, Cristofanilli M, Yang H. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer. Breast Cancer Res Treat. 2017 Jan; 161(1):83-94. PMID: 27771841.
      Citations:    
    38. Myers RE, Wolf T, Shwae P, Hegarty S, Peiper SC, Waldman SA. A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients. BMC Cancer. 2016 Oct 03; 16(1):766. PMID: 27716119.
      Citations:    
    39. Hamilton JG, Lillie SE, Alden DL, Scherer L, Oser M, Rini C, Tanaka M, Baleix J, Brewster M, Craddock Lee S, Goldstein MK, Jacobson RM, Myers RE, Zikmund-Fisher BJ, Waters EA. What is a good medical decision? A research agenda guided by perspectives from multiple stakeholders. J Behav Med. 2017 Feb; 40(1):52-68. PMID: 27566316.
      Citations:    
    40. Myers RE, Leader AE, Censits JH, Trabulsi EJ, Keith SW, Petrich AM, Quinn AM, Den RB, Hurwitz MD, Lallas CD, Hegarty SE, Dicker AP, Zeigler-Johnson CM, Giri VN, Ayaz H, Gomella LG. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study. J Cancer Educ. 2016 Jul 15. PMID: 27418065.
      Citations:    
    41. Li L, Hann HW, Wan S, Hann RS, Wang C, Lai Y, Ye X, Evans A, Myers RE, Ye Z, Li B, Xing J, Yang H. Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection. Sci Rep. 2016; 6:23992. PMID: 27063412.
      Citations:    
    42. Lai Y, Wang C, Civan JM, Palazzo JP, Ye Z, Hyslop T, Lin J, Myers RE, Li B, Jiang B, Sama A, Xing J, Yang H. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study. Gastroenterology. 2016 May; 150(5):1135-46. PMID: 26836586.
      Citations:    
    43. Mu Z, Wang C, Ye Z, Austin L, Civan J, Hyslop T, Palazzo JP, Jaslow R, Li B, Myers RE, Jiang J, Xing J, Yang H, Cristofanilli M. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer. Breast Cancer Res Treat. 2015 Dec; 154(3):563-71. PMID: 26573830.
      Citations:    
    44. Lai Y, Ye Z, Civan JM, Wang C, Cristofanilli M, Mu Z, Austin L, Palazzo JP, Myers RE, Yang H. The effects of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based study. Breast Cancer Res Treat. 2015 Sep; 153(2):407-16. PMID: 26264468.
      Citations:    
    45. Myers RE, Ruth K, Manne SL, Cocroft J, Sifri R, Ziring B, Burgh D, Ross E, Weinberg DS. Effects of genetic and environmental risk assessment feedback on colorectal cancer screening adherence. J Behav Med. 2015 Oct; 38(5):777-86. PMID: 25783675.
      Citations:    
    46. Wang C, Hann HW, Hann RS, Wan S, Myers RE, Ye Z, Xing J, Yang H. Circulating mitochondrial DNA content associated with the risk of liver cirrhosis: a nested case-control study. Dig Dis Sci. 2015 Jun; 60(6):1707-15. PMID: 25588520.
      Citations:    
    47. Hann HW, Wan S, Lai Y, Hann RS, Myers RE, Patel F, Zhang K, Ye Z, Wang C, Yang H. Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol. 2015 Jan; 30(1):131-8. PMID: 24995497.
      Citations:    
    48. Myers RE, Sifri R, Daskalakis C, DiCarlo M, Geethakumari PR, Cocroft J, Minnick C, Brisbon N, Vernon SW. Increasing colon cancer screening in primary care among african americans. J Natl Cancer Inst. 2014 Dec; 106(12). PMID: 25481829.
      Citations:    
    49. Ritvo PG, Myers RE, Paszat LF, Tinmouth JM, McColeman J, Mitchell B, Serenity M, Rabeneck L. Personal navigation increases colorectal cancer screening uptake. Cancer Epidemiol Biomarkers Prev. 2015 Mar; 24(3):506-11. PMID: 25378365.
      Citations:    
    50. Wang C, Civan J, Lai Y, Cristofanilli M, Hyslop T, Palazzo JP, Myers RE, Li B, Ye Z, Zhang K, Xing J, Yang H. Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables. Cancer Causes Control. 2015 Jan; 26(1):45-56. PMID: 25359303.
      Citations:    
    51. Weinberg DS, Myers RE, Keenan E, Ruth K, Sifri R, Ziring B, Ross E, Manne SL. Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial. Ann Intern Med. 2014 Oct 21; 161(8):537-45. PMID: 25329201.
      Citations:    
    52. Lai Y, Palazzo JP, Cristofanilli M, Hyslop T, Civan J, Avery T, Myers RE, Li B, Ye Z, Xing J, Yang H. Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy. Breast Cancer Res Treat. 2014 Nov; 148(1):175-85. PMID: 25261294.
      Citations:    
    53. Zhang K, Lai Y, Axelrod R, Campling B, Hyslop T, Civan J, Solomides C, Myers RE, Lu B, Bar Ad V, Li B, Ye Z, Yang H. Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests. Int J Cancer. 2015 Jan 15; 136(2):382-91. PMID: 24866905.
      Citations:    
    54. Daskalakis C, Vernon SW, Sifri R, DiCarlo M, Cocroft J, Sendecki JA, Myers RE. The effects of test preference, test access, and navigation on colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 2014 Aug; 23(8):1521-8. PMID: 24813819.
      Citations:    
    55. Nojomi M, Namiranian N, Myers RE, Razavi-Ratki SK, Alborzi F. Factors Associated with Breast Cancer Screening Decision Stage among Women in Tehran, Iran. Int J Prev Med. 2014 Feb; 5(2):196-202. PMID: 24627747.
      Citations:    
    56. Lairson DR, Dicarlo M, Deshmuk AA, Fagan HB, Sifri R, Katurakes N, Cocroft J, Sendecki J, Swan H, Vernon SW, Myers RE. Cost-effectiveness of a standard intervention versus a navigated intervention on colorectal cancer screening use in primary care. Cancer. 2014 Apr 1; 120(7):1042-9. PMID: 24435411.
      Citations:    
    57. Wan S, Lai Y, Myers RE, Li B, Hyslop T, London J, Chatterjee D, Palazzo JP, Burkart AL, Zhang K, Xing J, Yang H. Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients. J Gastrointest Cancer. 2013 Sep; 44(3):293-304. PMID: 23549858.
      Citations:    
    58. Ye Z, Palazzo JP, Lin L, Lai Y, Guiles F, Myers RE, Han J, Xing J, Yang H. Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients. J Gastroenterol Hepatol. 2013 Sep; 28(9):1469-75. PMID: 23611210.
      Citations:    
    59. Wan S, Lai Y, Myers RE, Li B, Palazzo JP, Burkart AL, Chen G, Xing J, Yang H. Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies - results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers. BMC Cancer. 2013; 13:340. PMID: 23841898.
      Citations:    
    60. Ritvo P, Myers RE, Paszat L, Serenity M, Perez DF, Rabeneck L. Gender differences in attitudes impeding colorectal cancer screening. BMC Public Health. 2013; 13:500. PMID: 23706029.
      Citations:    
    61. Yang H, Qu F, Myers RE, Bao G, Hyslop T, Hu G, Fei F, Xing J. Genetic variations in stem cell-related genes and colorectal cancer prognosis. J Gastrointest Cancer. 2012 Dec; 43(4):584-93. PMID: 22528324.
      Citations:    
    62. Hall MJ, Manne SL, Myers RE, Keenan EM, Balshem AM, Weinberg DS. Predictors of patient uptake of colorectal cancer gene environment risk assessment. Genome Med. 2012; 4(11):92. PMID: 23194586.
      Citations:    
    63. Myers RE, Bittner-Fagan H, Daskalakis C, Sifri R, Vernon SW, Cocroft J, Dicarlo M, Katurakes N, Andrel J. A randomized controlled trial of a tailored navigation and a standard intervention in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):109-17. PMID: 23118143.
      Citations:    
    64. Hann HW, Wan S, Myers RE, Hann RS, Xing J, Chen B, Yang H. Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients. PLoS One. 2012; 7(10):e47687. PMID: 23112834.
      Citations:    
    65. Wan S, Hann HW, Myers RE, Fu X, Hann RS, Kim SH, Tang H, Xing J, Yang H. Telomere length in circulating serum DNA as a novel non-invasive biomarker for cirrhosis: a nested case-control analysis. Liver Int. 2012 Sep; 32(8):1233-41. PMID: 22471856.
      Citations:    
    66. Dai J, Wan S, Zhou F, Myers RE, Guo X, Li B, Fu X, Palazzo JP, Dou K, Yang H, Xing J. Genetic polymorphism in a VEGF-independent angiogenesis gene ANGPT1 and overall survival of colorectal cancer patients after surgical resection. PLoS One. 2012; 7(4):e34758. PMID: 22496856.
      Citations:    
    67. Fu X, Wan S, Hann HW, Myers RE, Hann RS, Au J, Chen B, Xing J, Yang H. Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection. Eur J Cancer. 2012 May; 48(7):1014-22. PMID: 22444598.
      Citations:    
    68. Hann HW, Fu X, Myers RE, Hann RS, Wan S, Kim SH, Au N, Xing J, Yang H. Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection--results from a clinic-based longitudinal cohort. Eur J Cancer. 2012 Oct; 48(15):2319-27. PMID: 22436980.
      Citations:    
    69. Sarfaty M, Myers RE, Harris DM, Borsky AE, Sifri R, Cocroft J, Stello B, Johnson M. Variation in colorectal cancer screening steps in primary care: basis for practice improvement. Am J Med Qual. 2012 Nov; 27(6):458-66. PMID: 22267818.
      Citations:    
    70. Dong G, Guo X, Fu X, Wan S, Zhou F, Myers RE, Bao G, Burkart A, Yang H, Xing J. Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer. Cancer Sci. 2012 Mar; 103(3):561-8. PMID: 22182247.
      Citations:    
    71. Fagan HB, Wender R, Myers RE, Petrelli N. Obesity and Cancer Screening according to Race and Gender. J Obes. 2011; 2011:218250. PMID: 22220270.
      Citations:    
    72. Fagan HB, Myers RE, Daskalakis C, Sifri R, Mainous AG, Wender R. Race/Ethnicity, gender, weight status, and colorectal cancer screening. J Obes. 2011; 2011:314619. PMID: 22187635.
      Citations:    
    73. Xing J, Wan S, Zhou F, Qu F, Li B, Myers RE, Fu X, Palazzo JP, He X, Chen Z, Yang H. Genetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2012 Jan; 21(1):217-27. PMID: 22028396.
      Citations:    
    74. Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T, Dicker A, Wender R. Screening for prostate cancer: the current evidence and guidelines controversy. Can J Urol. 2011 Oct; 18(5):5875-83. PMID: 22018148.
      Citations:    
    75. Leader A, Daskalakis C, Braddock CH, Kunkel EJ, Cocroft JR, Bereknyei S, Riggio JM, Capkin M, Myers RE. Measuring informed decision making about prostate cancer screening in primary care. Med Decis Making. 2012 Mar-Apr; 32(2):327-36. PMID: 21685377.
      Citations:    
    76. Feldstein AC, Perrin N, Liles EG, Smith DH, Rosales AG, Schneider JL, Lafata JE, Myers RE, Mosen DM, Glasgow RE. Primary care colorectal cancer screening recommendation patterns: associated factors and screening outcomes. Med Decis Making. 2012 Jan-Feb; 32(1):198-208. PMID: 21652776.
      Citations:    
    77. Xing J, Myers RE, He X, Qu F, Zhou F, Ma X, Hyslop T, Bao G, Wan S, Yang H, Chen Z. GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis. Eur J Cancer. 2011 Jul; 47(11):1699-707. PMID: 21402474.
      Citations:    
    78. Parks SM, Winter L, Santana AJ, Parker B, Diamond JJ, Rose M, Myers RE. Family factors in end-of-life decision-making: family conflict and proxy relationship. J Palliat Med. 2011 Feb; 14(2):179-84. PMID: 21254816.
      Citations:    
    79. Siddiqui AA, Sifri R, Hyslop T, Andrel J, Rosenthal M, Vernon SW, Cocroft J, Myers RE. Race and response to colon cancer screening interventions. Prev Med. 2011 Mar-Apr; 52(3-4):262-4. PMID: 21256149.
      Citations:    
    80. Tinmouth J, Ritvo P, McGregor SE, Claus D, Pasut G, Myers RE, Guglietti C, Paszat LF, Hilsden RJ, Rabeneck L. A qualitative evaluation of strategies to increase colorectal cancer screening uptake. Can Fam Physician. 2011 Jan; 57(1):e7-15. PMID: 21322288.
      Citations:    
    81. McQueen A, Vernon SW, Rothman AJ, Norman GJ, Myers RE, Tilley BC. Examining the role of perceived susceptibility on colorectal cancer screening intention and behavior. Ann Behav Med. 2010 Oct; 40(2):205-17. PMID: 20658212.
      Citations:    
    82. Flight IH, Wilson CJ, McGillivray J, Myers RE. Cross-cultural validation of the preventive health model for colorectal cancer screening: an Australian study. Health Educ Behav. 2010 Oct; 37(5):724-36. PMID: 20930134.
      Citations:    
    83. Myers RE, Manne SL, Wilfond B, Sifri R, Ziring B, Wolf TA, Cocroft J, Ueland A, Petrich A, Swan H, DiCarlo M, Weinberg DS. A randomized trial of genetic and environmental risk assessment (GERA) for colorectal cancer risk in primary care: trial design and baseline findings. Contemp Clin Trials. 2011 Jan; 32(1):25-31. PMID: 20828635.
      Citations:    
    84. Myers RE, Daskalakis C, Kunkel EJ, Cocroft JR, Riggio JM, Capkin M, Braddock CH. Mediated decision support in prostate cancer screening: a randomized controlled trial of decision counseling. Patient Educ Couns. 2011 May; 83(2):240-6. PMID: 20619576.
      Citations:    
    85. Mosen DM, Feldstein AC, Perrin N, Rosales AG, Smith DH, Liles EG, Schneider JL, Lafata JE, Myers RE, Kositch M, Hickey T, Glasgow RE. Automated telephone calls improved completion of fecal occult blood testing. Med Care. 2010 Jul; 48(7):604-10. PMID: 20508529.
      Citations:    
    86. Sifri R, Rosenthal M, Hyslop T, Andrel J, Wender R, Vernon SW, Cocroft J, Myers RE. Factors associated with colorectal cancer screening decision stage. Prev Med. 2010 Sep-Oct; 51(3-4):329-31. PMID: 20600255.
      Citations:    
    87. Jimbo M, Myers RE, Meyer B, Hyslop T, Cocroft J, Turner BJ, Weinberg DS. Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann Fam Med. 2009 Jan-Feb; 7(1):11-6. PMID: 19139444.
      Citations:    
    88. Bittner Fagan H, Diamond J, Myers R, Gill JM. Perception, intention, and action in adolescent obesity. J Am Board Fam Med. 2008 Nov-Dec; 21(6):555-61. PMID: 18988723.
      Citations:    
    89. Myers RE, Hyslop T, Sifri R, Bittner-Fagan H, Katurakes NC, Cocroft J, Dicarlo M, Wolf T. Tailored navigation in colorectal cancer screening. Med Care. 2008 Sep; 46(9 Suppl 1):S123-31. PMID: 18725824.
      Citations:    
    90. Sarfaty M, Myers RE. The effect of HEDIS measurement of colorectal cancer screening on insurance plans in Pennsylvania. Am J Manag Care. 2008 May; 14(5):277-82. PMID: 18471032.
      Citations:    
    91. Lairson DR, DiCarlo M, Myers RE, Wolf T, Cocroft J, Sifri R, Rosenthal M, Vernon SW, Wender R. Cost-effectiveness of targeted and tailored interventions on colorectal cancer screening use. Cancer. 2008 Feb 15; 112(4):779-88. PMID: 18098272.
      Citations:    
    92. Myers RE, Sifri R, Hyslop T, Rosenthal M, Vernon SW, Cocroft J, Wolf T, Andrel J, Wender R. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer. 2007 Nov 1; 110(9):2083-91. PMID: 17893869.
      Citations:    
    93. Myers RE. Patient preferences for colorectal cancer screening. Am J Manag Care. 2007 Nov; 13(11):633-4; author reply 634, 636. PMID: 17988189.
      Citations:    
    94. Myers RE, Weinberg DS, Manne SL, Sifri R, Cocroft J, Kash K, Wilfond B. Genetic and environmental risk assessment for colorectal cancer risk in primary care practice settings: a pilot study. Genet Med. 2007 Jun; 9(6):378-84. PMID: 17575504.
      Citations:    
    95. McQueen A, Vernon SW, Myers RE, Watts BG, Lee ES, Tilley BC. Correlates and predictors of colorectal cancer screening among male automotive workers. Cancer Epidemiol Biomarkers Prev. 2007 Mar; 16(3):500-9. PMID: 17372245.
      Citations:    
    96. Jimbo M, Meyer B, Hyslop T, Cocroft J, Turner BJ, Weinberg DS, Myers RE. Effectiveness of complete diagnostic examination in clinical practice settings. Cancer Detect Prev. 2006; 30(6):545-51. PMID: 17113240.
      Citations:    
    97. Myers RE, Berry A, Bradley P, Cocroft J, Daskalakis C, Delmoor E, Fleisher L, Kasper-Keintz M, Witt D. Increasing access to clinical and educational studies. Cancer. 2006 Oct 15; 107(8 Suppl):1962-70. PMID: 16986164.
      Citations:    
    98. Bradley PK, Berry A, Lang C, Myers RE. Getting ready: developing an educational intervention to prepare African American women for breast biopsy. ABNF J. 2006 Jan-Feb; 17(1):15-9. PMID: 16596896.
      Citations:    
    99. Tiro JA, Vernon SW, Hyslop T, Myers RE. Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 2005 Dec; 14(12):2855-61. PMID: 16365000.
      Citations:    
    100. Bradley PK, Kash KM, Piccoli CW, Myers RE. Preparing African American women for breast biopsy. Cancer Control. 2005 Nov; 12 Suppl 2:100-2. PMID: 16327759.
      Citations:    
    101. Myers RE, Daskalakis C, Cocroft J, Kunkel EJ, Delmoor E, Liberatore M, Nydick RL, Brown ER, Gay RN, Powell T, Powell RL. Preparing African-American men in community primary care practices to decide whether or not to have prostate cancer screening. J Natl Med Assoc. 2005 Aug; 97(8):1143-54. PMID: 16173330.
      Citations:    
    102. Myers RE. Decision counseling in cancer prevention and control. Health Psychol. 2005 Jul; 24(4 Suppl):S71-7. PMID: 16045422.
      Citations:    
    103. Bastani R, Yabroff KR, Myers RE, Glenn B. Interventions to improve follow-up of abnormal findings in cancer screening. Cancer. 2004 Sep 1; 101(5 Suppl):1188-200. PMID: 15316914.
      Citations:    
    104. Weinberg DS, Turner BJ, Wang H, Myers RE, Miller S. A survey of women regarding factors affecting colorectal cancer screening compliance. Prev Med. 2004 Jun; 38(6):669-75. PMID: 15193887.
      Citations:    
    105. Myers RE, Turner B, Weinberg D, Hyslop T, Hauck WW, Brigham T, Rothermel T, Grana J, Schlackman N. Impact of a physician-oriented intervention on follow-up in colorectal cancer screening. Prev Med. 2004 Apr; 38(4):375-81. PMID: 15020170.
      Citations:    
    106. Kunkel EJ, Meyer B, Daskalakis C, Cocroft J, Jennings-Dozier K, Myers RE. Behaviors used by men to protect themselves against prostate cancer. Cancer Epidemiol Biomarkers Prev. 2004 Jan; 13(1):78-86. PMID: 14744737.
      Citations:    
    107. Baig N, Myers RE, Turner BJ, Grana J, Rothermel T, Schlackman N, Weinberg DS. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol. 2003 Sep; 98(9):2078-81. PMID: 14499791.
      Citations:    
    108. Turner B, Myers RE, Hyslop T, Hauck WW, Weinberg D, Brigham T, Grana J, Rothermel T, Schlackman N. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test. J Gen Intern Med. 2003 May; 18(5):357-63. PMID: 12795734.
      Citations:    
    109. Watts BG, Vernon SW, Myers RE, Tilley BC. Intention to be screened over time for colorectal cancer in male automotive workers. Cancer Epidemiol Biomarkers Prev. 2003 Apr; 12(4):339-49. PMID: 12692109.
      Citations:    
    Myers's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (206)
    Explore
    _
    Co-Authors (95)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _